Published in J Steroid Biochem Mol Biol on December 28, 2009
Assessing and treating insulin resistance in women with polycystic ovarian syndrome. World J Diabetes (2011) 1.02
Functional link between bone morphogenetic proteins and insulin-like peptide 3 signaling in modulating ovarian androgen production. Proc Natl Acad Sci U S A (2013) 0.98
Systemic SIRT1 insufficiency results in disruption of energy homeostasis and steroid hormone metabolism upon high-fat-diet feeding. FASEB J (2011) 0.91
Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats. Reprod Biol Endocrinol (2012) 0.85
Prevalence and clinical predictors of insulin resistance in reproductive-aged thai women with polycystic ovary syndrome. Int J Endocrinol (2012) 0.82
Predictors of insulin resistance and metabolic complications in polycystic ovarian syndrome in an eastern Indian population. Indian J Clin Biochem (2012) 0.82
Does ovary need D-chiro-inositol? J Ovarian Res (2012) 0.81
Effects of diet-induced obesity on metabolic parameters and reproductive function in female Ossabaw minipigs. Comp Med (2014) 0.81
Polycystic diseases in visceral organs. Obstet Gynecol Int (2011) 0.79
The association between polymorphism of INSR and polycystic ovary syndrome: a meta-analysis. Int J Mol Sci (2015) 0.79
Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells. Steroids (2012) 0.78
AMP-activated protein kinase is a key intermediary in GnRH-stimulated LHβ gene transcription. Mol Endocrinol (2013) 0.78
Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation. Reprod Sci (2014) 0.78
Benefits of omega-3 Fatty acids supplementation on serum paraoxonase 1 activity and lipids ratios in polycystic ovary syndrome. Health Promot Perspect (2012) 0.77
Correlations of Insulin Resistance and Serum Testosterone Levels with LH:FSH Ratio and Oxidative Stress in Women with Functional Ovarian Hyperandrogenism. Indian J Clin Biochem (2014) 0.75
Association Analysis between the Polymorphisms of HSD11B1 and H6PD and Risk of Polycystic Ovary Syndrome in Chinese Population. PLoS One (2015) 0.75
Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome. Yonsei Med J (2016) 0.75
Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study. Hum Reprod (2016) 0.75
Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy. Exp Ther Med (2017) 0.75
Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. J Res Med Sci (2017) 0.75
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril (2004) 12.87
IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science (1996) 8.57
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell (2000) 7.26
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev (1997) 5.83
Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci U S A (1999) 5.81
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab (1999) 5.28
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev (2002) 4.41
Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med (2008) 4.07
Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev (2004) 3.58
Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J Biol Chem (2005) 3.04
Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med (1996) 2.77
Signaling mechanisms that regulate glucose transport. J Biol Chem (1999) 2.75
Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab (2000) 2.69
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab (2001) 2.66
Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J Biol Chem (1998) 2.25
Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest (2003) 2.18
Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab (1998) 2.10
Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. Mol Biol Cell (2004) 2.09
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab (1991) 1.96
Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes (2001) 1.93
The insulin-related ovarian regulatory system in health and disease. Endocr Rev (1999) 1.90
Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med (1992) 1.83
17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss. J Clin Endocrinol Metab (1997) 1.83
Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril (2008) 1.78
Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord (2002) 1.77
Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab (2002) 1.67
Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab (2005) 1.67
Glucose effects on beta-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2. Mol Cell Biol (2009) 1.66
Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev (1995) 1.63
The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem (2003) 1.59
Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance. Eur J Endocrinol (2007) 1.58
Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertil Steril (2007) 1.55
Effects of obesity on women's reproduction and complications during pregnancy. Obes Rev (2004) 1.53
Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab (2003) 1.52
Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial. Gynecol Endocrinol (2010) 1.47
Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome. Fertil Steril (1999) 1.46
Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med (2006) 1.44
The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG (2006) 1.44
Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci U S A (1995) 1.44
Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 1.44
Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab (2003) 1.42
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol (1992) 1.37
Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) (1997) 1.34
Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab (2004) 1.33
Adrenal cholesterol utilization. Mol Cell Endocrinol (2007) 1.32
Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest (1995) 1.32
Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab (2001) 1.31
A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate. Diabetes (2001) 1.29
Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab (2002) 1.28
ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in the adrenal cortex. Microsc Res Tech (2003) 1.28
Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab (1992) 1.26
Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab (1995) 1.23
Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. Am J Physiol Endocrinol Metab (2009) 1.21
Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril (2004) 1.21
Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab (1997) 1.21
The regulation of 17,20 lyase activity. Steroids (1997) 1.20
Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 1.20
Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab (1996) 1.18
Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Mol Endocrinol (2004) 1.18
Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling. Mol Pharmacol (2005) 1.16
Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. Diabetes (2007) 1.16
Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab (1999) 1.15
Steroidogenic enzymes. Endocr Dev (2008) 1.14
Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. Fertil Steril (2003) 1.13
Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species. Biochemistry (1999) 1.13
Insulin augmentation of 17alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells. Endocrinology (2003) 1.12
Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J Biol Chem (2005) 1.12
Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. Hum Reprod (2000) 1.11
The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab (2001) 1.09
The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod (2006) 1.08
Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril (2003) 1.08
Metformin has direct effects on human ovarian steroidogenesis. Fertil Steril (2003) 1.08
A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril (2004) 1.07
Ovarian steroids: the good, the bad, and the signals that raise them. Cell Cycle (2006) 1.05
Adrenocortical zonation and ACTH. Microsc Res Tech (2003) 1.05
The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab (1996) 1.04
Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production. J Clin Endocrinol Metab (2005) 1.03
The insulin receptor--a critical link in glucose homeostasis and insulin action. J Basic Clin Physiol Pharmacol (1998) 1.03
Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med (1989) 1.03
Human ovarian theca cells in culture. Trends Endocrinol Metab (2006) 0.98
Mechanisms in the regulation of aromatase in developing ovary and placenta. J Steroid Biochem Mol Biol (2007) 0.98
Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J Clin Endocrinol Metab (1990) 0.97
Immunolocalization of aromatase, 17 alpha-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. J Reprod Fertil (1989) 0.97
Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight. Clin Endocrinol (Oxf) (2001) 0.96
Role of diet in the treatment of polycystic ovary syndrome. Fertil Steril (2006) 0.95
Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2. Mol Pharmacol (2006) 0.95
Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. J Clin Endocrinol Metab (1997) 0.95
Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway. Endocrinology (2009) 0.95
Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity. Diabetologia (1997) 0.94
The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest (2005) 0.94
An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome. Fertil Steril (2009) 0.93
Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance. J Clin Endocrinol Metab (2004) 0.93
Characterization of insulin-like growth factor I and insulin receptors on cultured bovine adrenal fasciculata cells. Role of these peptides on adrenal cell function. Endocrinology (1988) 0.93
The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril (1984) 0.93
Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 0.92
Pathways leading to phosphorylation of p450c17 and to the posttranslational regulation of androgen biosynthesis. Endocrinology (2008) 0.92
Molecular target of endocrine disruption in human luteinizing granulosa cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin: inhibition of estradiol secretion due to decreased 17alpha-hydroxylase/17,20-lyase cytochrome P450 expression. Endocrinology (2003) 0.92
Alteration in insulin action: role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling. Ann Endocrinol (Paris) (2004) 0.92
Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro. Fertil Steril (2010) 1.49
Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study. Diabetes Care (2010) 1.25
Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial. CMAJ (2005) 1.20
Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. Endocr Pract (2004) 1.15
Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol (2007) 1.14
Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics (2013) 1.13
Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care (2013) 1.06
On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans. Am J Physiol Endocrinol Metab (2005) 1.04
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity. Am J Physiol Endocrinol Metab (2007) 1.03
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril (2008) 1.03
Lower vitamin D levels at first trimester are associated with higher risk of developing gestational diabetes mellitus. Acta Diabetol (2014) 1.01
Prevalence and predictors of vitamin D insufficiency in women of reproductive age living in northern latitude. Eur J Endocrinol (2010) 1.01
Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes. Diabetes Res Clin Pract (2010) 1.01
Perinatal exposure to low-dose 2,2',4,4'-tetrabromodiphenyl ether affects growth in rat offspring: what is the role of IGF-1? Toxicology (2009) 0.96
Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans. Am J Physiol Endocrinol Metab (2006) 0.91
Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metabolism (2008) 0.91
Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome. Metabolism (2010) 0.90
Metabolically healthy obese women and functional capacity. Metab Syndr Relat Disord (2011) 0.89
Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy. J Clin Endocrinol Metab (2004) 0.88
Basic infertility including polycystic ovary syndrome. Med Clin North Am (2008) 0.88
Intergenerational cycle of obesity and diabetes: how can we reduce the burdens of these conditions on the health of future generations? Exp Diabetes Res (2011) 0.87
Steroidogenesis-adrenal cell signal transduction. Compr Physiol (2014) 0.86
Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome. Fertil Steril (2010) 0.86
TNFα dynamics during the oral glucose tolerance test vary according to the level of insulin resistance in pregnant women. J Clin Endocrinol Metab (2014) 0.85
A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills. J Clin Endocrinol Metab (2003) 0.85
Pilot study: can older inactive adults learn how to reach the required intensity of physical activity guideline? Clin Interv Aging (2013) 0.85
Oral hypoglycemic agents for gestational diabetes mellitus? Expert Opin Drug Saf (2011) 0.85
Effectiveness of a multidisciplinary program for management of obesity: the Unité d'Enseignement, de Traitement et de Recherche sur l'Obésité (UETRO) database study. Metab Syndr Relat Disord (2009) 0.84
Comparison of foot-to-foot and hand-to-foot bioelectrical impedance methods in a population with a wide range of body mass indices. Metab Syndr Relat Disord (2010) 0.84
Age differences in expectations and readiness regarding lifestyle modifications in individuals at high risk of diabetes. Arch Phys Med Rehabil (2012) 0.83
Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats. Am J Physiol Endocrinol Metab (2012) 0.83
Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer. Prostate (2013) 0.83
Risk of type 2 diabetes and cumulative excess weight exposure in the Framingham Offspring Study. J Diabetes Complications (2013) 0.82
Fetal adrenal gland alterations in a rat model of adverse intrauterine environment. Am J Physiol Regul Integr Comp Physiol (2009) 0.80
Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome. CMAJ (2007) 0.80
Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome. Fertil Steril (2012) 0.79
Impact of health professionals' contact frequency on response to a lifestyle intervention with individuals at high risk for diabetes. Diabetes Res Clin Pract (2012) 0.79
Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells. Steroids (2012) 0.78
Reference ranges for total and calculated free and bioavailable testosterone in a young healthy women population with normal menstrual cycles or using oral contraception. Clin Biochem (2011) 0.77
Impact of maternal use of asthma-controller therapy on perinatal outcomes. Thorax (2013) 0.77
Epigenetic dysregulation of the IGF system in placenta of newborns exposed to maternal impaired glucose tolerance. Epigenomics (2014) 0.77
The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and β-cell function. Br J Nutr (2015) 0.77
Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome. Int J Pediatr Endocrinol (2012) 0.77
From integrative signalling to metabolic disorders. J Steroid Biochem Mol Biol (2008) 0.77
PCOS in adolescence and type 2 diabetes. Curr Diab Rep (2015) 0.77
Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice. Fertil Steril (2010) 0.76
Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose: comment on agarwal, dhatt, and shah. Diabetes Care (2010) 0.76
Ovulation induction in polycystic ovary syndrome-how do metformin and clomifene citrate compare? Nat Clin Pract Endocrinol Metab (2007) 0.75
Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity. Metabolism (2009) 0.75
Dietary conjugated α-linolenic acid did not improve glucose tolerance in a neonatal pig model. Eur J Nutr (2013) 0.75
Physical Activity Assessment and Counseling: Quebec Primary Health Care Providers' Current Practice: 2694 Board #217 June 3, 11: 00 AM - 12: 30 PM. Med Sci Sports Exerc (2016) 0.75
Associations of Maternal Leptin with Neonatal Adiposity Differ according to Pregravid Weight. Neonatology (2017) 0.75
Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome. Endocrinology (2014) 0.75